
GC16345
Bropirimine
Also known as 2-amino-5-bromo-4-phenyl-1H-pyrimidin-6-one
Bropirimine is a synthetic agonist for toll-like receptor 7 (TLR7)· Bropirimine inhibits differentiation of osteoclast precursor cells into osteoclasts via TLR7-mediated production of IFN-β· Bropirimine is an orally active immunomodulator that has demonstrated anticancer activity in transitional cell carcinoma in situ (CIS) in both the bladder and upper urinary tract
ChemicalCAS56741-95-8MW266.09FormulaC10H8BrN3O
- CAS number
- 56741-95-8
- Molecular weight
- 266.09
- Formula
- C10H8BrN3O
- Solubility
- <26·61mg/ml in DMSO
- InChIKey
- CIUUIPMOFZIWIZ-UHFFFAOYSA-N
- Catalogue number
- GC16345
- Brand
- GLPBIO
Computed properties PubChem CID 135413497 · XLogP 1.2 · TPSA 67.5 Ų · H-bond donors 2
- XLogP
- 1.2
- TPSA
- 67.5 Ų
- H-bond donors
- 2
- H-bond acceptors
- 2
- Rotatable bonds
- 1
- Heavy atoms
- 15
SMILES C1=CC=C(C=C1)C2=C(C(=O)NC(=N2)N)Br
Computed descriptors from PubChem (CID 135413497), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il